EU Slaps US Pharma: Pay Tariffs Or Swallow Pills Harder
Photo by Kaptured by Kasia on Unsplash
In a masterstroke of diplomatic irony, the European Union’s new trade deal might cost US pharmaceuticals between $13 and $19 billion as their "branded medicines become subject to a tariff of 15%," analysts grimly noted on Monday. Despite exporting the largest share of medicines to America—about 60% of all pharma imports—Europe’s latest move feels like charging admission before giving the aspirin. As the article put it, "Medicines are the largest European exports to the U.S. by value," which is rich, considering the US now pays extra just to get these pricey pills past customs.
Share the Story
(1 of 3)Source: Feeds | Published: 7/28/2025 | Author: Reuters
More Articles in Business
Army Launches 9-1-1 Hotline Because Soldiers Really Love Calling IT
Businessinsider
Microsoft Finally Lets Windows 11 Fans Stop Pretending to Use ViVeTool
Theverge
Epstein Survivors Declare 'Done' While Melania Passes the Buck Faster Than a Baton
Theguardian
Entrepreneurs Swear By Hulkens, Because Carrying Packages in Style is a Hustle
Businessinsider
Walmart Cuts H-1B Visa Applications by Half, Still Outselling Visa Restrictions
Businessinsider
Bobbi Brown Got Fired, Didn't Cry, Just Launched Another Empire
Businessinsider
Texas Company Turns Man Camps Into Mansion Camps for AI Construction Bros
Businessinsider
Volkswagen Kills Its Own EV Baby, Prefers Gas-Guzzling Siblings
Businessinsider
Amazon CEO Makes $2.1M Mostly Traveling and Avoiding Danger, Stocks Optional
Businessinsider